moonslav59

We'd probably have to give up ERod or Wright plus 2 or 3 of out top 4-5 prospects.

MLBTR reports.... By Jeff Todd | March 3, 2017 at 3:26pm CDT The Red Sox announced some very welcome news on lefty David Price, who was being evaluated for a worrying elbow injury. As Rob Bradford of WEEI.com was among those to report on Twitter, manager John Farrell says that Price is not expected to require surgery or other invasive treatments. Instead, he will be shut down for seven to ten days of treatment before being reevaluated. It’s not immediately clear how soon Price can be expected back on the mound. The injury has been diagnosed as a strain, per Jason Mastrodonato of the Boston Herald (via Twitter), which presumably could have a wide variance in recovery process and timing. Clearly, though, the news comes as a relief to a Boston organization that has much at stake in Price’s left arm — this season and beyond. Alarm bells rang yesterday when the Sox told reporters they were sending Price to be examined by elbow experts Dr. James Andrews and Dr. Neal ElAttrache. That decision showed that the team had real concern, and raised the specter of a season-ending surgery. Those two physicians, after all, are among the foremost practitioners of the Tommy John procedure. While a visit to their offices often precedes a TJ procedure, though, that’s not always the case. In Price’s situation, it seems, other treatment outcomes were also seen as being on the table. Ferrell noted that the veteran southpaw won’t need an injection, which perhaps would have represented an alternative. As it turns out, the news represents a best-case scenario. Unfortunately, even with that good news, it seems as if Price may fall behind a bit. Unless, perhaps, he’s cleared for a full resumption of this throwing program at the earliest opportunity, Price may need to spend at least a bit of time on the DL to start the season. That wouldn’t be particularly problematic were it not for the fact that Boston is facing similar timing questions already with pitchers such as Steven Wright and Drew Pomeranz, though perhaps a fill-in or even an outside addition could help bridge the gap if the need arises.

MLBTR... y Jeff Todd | March 3, 2017 at 3:26pm CDT The Red Sox announced some very welcome news on lefty David Price, who was being evaluated for a worrying elbow injury. As Rob Bradford of WEEI.com was among those to report on Twitter, manager John Farrell says that Price is not expected to require surgery or other invasive treatments. Instead, he will be shut down for seven to ten days of treatment before being reevaluated. It’s not immediately clear how soon Price can be expected back on the mound. The injury has been diagnosed as a strain, per Jason Mastrodonato of the Boston Herald (via Twitter), which presumably could have a wide variance in recovery process and timing. Clearly, though, the news comes as a relief to a Boston organization that has much at stake in Price’s left arm — this season and beyond. Alarm bells rang yesterday when the Sox told reporters they were sending Price to be examined by elbow experts Dr. James Andrews and Dr. Neal ElAttrache. That decision showed that the team had real concern, and raised the specter of a season-ending surgery. Those two physicians, after all, are among the foremost practitioners of the Tommy John procedure. While a visit to their offices often precedes a TJ procedure, though, that’s not always the case. In Price’s situation, it seems, other treatment outcomes were also seen as being on the table. Ferrell noted that the veteran southpaw won’t need an injection, which perhaps would have represented an alternative. As it turns out, the news represents a best-case scenario. Unfortunately, even with that good news, it seems as if Price may fall behind a bit. Unless, perhaps, he’s cleared for a full resumption of this throwing program at the earliest opportunity, Price may need to spend at least a bit of time on the DL to start the season. That wouldn’t be particularly problematic were it not for the fact that Boston is facing similar timing questions already with pitchers such as Steven Wright and Drew Pomeranz, though perhaps a fill-in or even an outside addition could help bridge the gap if the need arises.

Yes, teams with more blowout wins have more opportunities to lose or tie a series after outscoring their opponents, but this is what sometimes gives fans the illusion of inconsistency or lack of being "clutch". As long as you win your fair share of close games, winning some games by blowout should not change any perceptions. Sample sizes are small: We won 3 games with walk-off hits and lost 6. We were 20-24 in 1 run games. That's 2 games from being 22-22. We won 30 games by blow out and lost 11 by blow out. We were 7-4 in extra inning games. Nothing here jumps out to say we have some sort of abnormality.

Apparently, he says he's going to be okay.

Depending on Johnson's emotional health, I'd put him ahead of Owens.

Although I'd have rather had Quintana and his extra year of team control over Sale, I agree. Trading for Q now would be insane.

I knew it was going to be bad. I'm sure glad we let him bolt.

We could try Workman as a starter again, or possibly move Kelly back to that role, despite his tiny sample size of success as a RP'er last fall. I doubt we move Barnes to starter, but he might do well there. He's looked good in the pen, so I'd hate to mess him up. My guess is that Elias or Johnson will be our first look candidates with Kendrick and Owens in the next tier. If all 4 fail, and we don't want to try Workman, Kelly or Barnes, we can look for a mid season pick-up.

By Steve Adams | March 3, 2017 at 11:08am CDT As the Red Sox await news on the fate of left-hander David Price, ESPN’s Buster Olney runs down the list of options for Boston in the event that Price is forced to sit out part of or all of the 2017 season (ESPN Insider subscription required and recommended). The Sox do still have five big league starters in the form of Chris Sale, Rick Porcello, Eduardo Rodriguez, Drew Pomeranz and Steven Wright, though each has come with recent injury troubles. Beyond that, the team is lacking in quality depth options, though Henry Owens, Brian Johnson, Roenis Elias and others are present in Pawtucket. Free agents such as Doug Fister, Colby Lewis and Jake Peavy are still on the market, and Jose Quintana, of course, looms on the trade market. Olney notes that the Red Sox would likely have to utilize top prospect Rafael Devers as the headliner in a theoretical Quintana deal, however. I'm not even sure Devers and Groome would net us Quintana. It would probably take Devers, Groome & Travis to just get the conversation started. That would essentially wipe out our entire upper ranked prospects.

March 3: Farrell said the Red Sox won’t get further word on Price’s elbow until at least the late afternoon today, tweets Jen McCaffrey of MassLive.com. March 2, 3:43pm: Price will receive opinions from both Andrews and ElAttrache in Indianapolis tomorrow, tweets Britton. (The renowned surgeons are both there for this week’s NFL combine.) Jason Mastrodonato of the Boston Herald tweets that Farrell said the initial MRI revealed some swelling and fluid buildup but offered “inconclusive” results overall. Peter Abraham of the Boston Globe tweets that Price himself is optimistic that the injury isn’t serious.

I just think we need about 360-400 IP from ERod, Wright and Pom combined. I think that is very doable. Last year, those three pitched over 430 IP. If Price misses a lot of time, we'll probably need over 500.

The main point is that we lost or tied 25% of our series last year despite outscoring our opponents. Does anybody know of another team that did worse in this area?

Thanks for the correction. I think I counted the runs as 10-10 and put that in the above category. My bad. Updated: When we scored more: W 24 T 4 L 4 When we tied in runs scored: W 0 T 0 L 1 When we were outscored: W 2 T 1 L 14

Here's our record last year by series wins-losses-ties When we scored more: W 24 T 4 L 4 When we tied in runs scored: W 0 T 1 L 1 When we were outscored: W 2 T 0 L 14

I'm not up for doing the research, but I'd like to know how many other teams outscored their opponents in a series and lost or tied as many as we did. With a high scoring team, I guess you'd expect more, but I think we might be surprised by how much more.

...looks like our title hopes might be Shot Down In Flames.... Why? From what I understand, Price sucks in the clutch, so maybe we'll be better off. ...just kidding!

It could be no tear. That's what I'm hoping for. Boy, that Sale trade looks even better now!

It might be nice to still have Buch, but I'm glad we shed his salary and the grief of always wondering when his next injury was going to occur. We can find a good starter who costs less than him, if we need one.

Last season, we had a stretch were we outscored our opponents in something like 8 out of 10 straight series, but tied or lost the series in half of them. It was a lot worse "in the old days", but it does still seem to happen more to us than to other teams. I'm not sure where you find the data for that.

I get what he meant, but it was worded funny. He's saying his bat is good enough that if he cannot be a plus fielder at 3B, he'll still have a job (at 1B). My point was that it would be better for him to hit like a 1Bman, but field well enough to stay at 3B.

David Price Undergoes MRI After Experiencing Elbow Soreness By Jeff Todd | March 2, 2017 at 8:46am CDT 9:48am: There is “serious concern” that Price may require Tommy John surgery, Bowden tweets. 8:46am: The Red Sox are holding their breath after sending in key lefty David Price for an MRI, as Jim Bowden of ESPN.com reports (Twitter links). For now, Price will just be held out of his next scheduled start while he heads for a second opinion. The broader outlook is not known, but manager John Farrell says there is concern given the degree of soreness Price is experiencing. And while it’s far from clear whether there’s reason yet to believe he could be headed for surgery, the veteran lefty is already slated to see one or both of the game’s foremost Tommy John experts — Dr. James Andrews and Dr. Neal ElAttrache — for a second opinion, per Tim Britton of the Providence Journal (via Twitter). Price, 31, signed a record-setting seven-year, $217MM with the Red Sox last winter. The agreement includes an opt-out opportunity after the 2018 campaign. He has earned only $30MM of the total thus far; needless to say, Boston has a lot riding on the lefty, both now and in the future. While his first season with the Red Sox didn’t pan out quite as hoped, with Price recording only a 3.99 ERA, he still managed to throw a typically robust 230 frames. Boston has hoped that he and newly added starter Chris Sale would provide a historically excellent 1-2 lefty punch, with reigning AL Cy Young winner Rick Porcello rounding out a top-flight front of the rotation. If the worst case comes to pass for Price, then the club does have three arms to round out the staff — Eduardo Rodriguez, Drew Pomeranz, and Steven Wright (assuming all remain on track with their respective health issues) — but little in the way of certainty beyond that. Boston president of baseball operations Dave Dombrowski previously shipped out veteran Clay Buchholz, but he has expressed confidence in the team’s remaining depth.

I'm not sure how his bat "profile" affects whether he plays 3B or 1B. Ideally, having a top hitting 1Bman that can play 3B as a plus fielder, would be better than forcing him to 1B, because he's hitting too good for 3B.

MLBTR... Red Sox Renew Mookie Betts For $950K By Jeff Todd | March 2, 2017 at 10:21am CDT The Red Sox have renewed outfielder Mookie Betts’ contract at a healthy $950K price, according to Alex Speier of the Boston Globe (via Twitter). Betts, 24, has established himself as one of the game’s best players and is fresh off of an outstanding 2016 season in which he slashed .318/.363/.534 with 31 home runs and 26 stolen bases. On the heels of that effort, Betts will take home the second-highest amount ever given to a 2+ service-class player who wasn’t eligible for arbitration, falling shy only of Mike Trout’s 2014 payday of $1MM. Nevertheless, the Red Sox weren’t able to get him to sign his name to the agreement. The club had the right to renew him at whatever amount it preferred, so long as it met or exceeded the league minimum salary, so it’s not as if he had much leverage. But it’s still somewhat notable that Betts was the organization’s only player to make the symbolic gesture of forcing the club to renew him. That being said, president of baseball operations Dave Dombrowski says that he did not sense any bad feelings between the sides during negotiations, as Tim Britton of the Providence Journal reports (Twitter links). Certainly, the club could have taken a harsher stance in setting the final number, but obviously had no interest in making a point at the expense of its relationship with a key player. As things turned out, says Betts, there’s no animosity on his part. (Via Michael Silverman of the Boston Herald, on Twitter.) It would not be surprising to see the sides back at the bargaining table sooner rather than later. If nothing else, there’ll be a hefty arbitration salary to negotiate next winter, but it’s also possible to imagine that the sides will explore a longer-term deal. While Boston enjoys three years of control over Betts beyond the upcoming season, the team’s leverage will wane as he gets closer to free agency and increases his earnings through the arb process.

He played 278 games at 1B over his career. True, he was a DH-only type player, but his weight was much higher than Devers. From what I have read and seen, Devers has big legs and "lower half". Usually, weight issues involve big guts. Scouting reports actually mention needing to "fill out" on his upper half. https://www.google.com/search?q=rafael+devers&safe=strict&rlz=1C1UDIB_enUS705US705&espv=2&biw=1920&bih=974&source=lnms&tbm=isch&sa=X&ved=0ahUKEwiKhK3OxLjSAhUHxFQKHfecCqoQ_AUICCgD Looking at the fotos, I'm not worried at all, and to say he's a bigger conditioning issue than Pablo is pure hyperbole.